Clinical trial
Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic…
NCT00257283 · Pronova BioPharma, Industry · Completed
Key facts
| NCT number | NCT00257283 |
|---|---|
| Title | Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis |
| Official title | A Double Blind Comparison of Omacor and Placebo as Secondary Prevention Against Cardiovascular Events in Patients Undergoing Chronic Hemodialysis |
| Lead sponsor | Pronova BioPharma, Industry |
| Collaborators | Danish Heart Foundation The Danish Kidney Association North Denmark Region |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | Omega-3-acid ethyl esters 90 |
| Enrollment | 200 |
| Start date | Nov 1, 2002 |
| Completion | Jun 1, 2005 |
| First posted | Nov 22, 2005 |
| Last update posted | Mar 11, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: